Causey Wealth LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Hold
7,262
0.16% 61
2026
Q1
$440K Hold
7,262
0.19% 57
2025
Q4
$392K Buy
7,262
+407
+6% +$19.6K 0.18% 54
2025
Q3
$309K Hold
6,855
0.15% 55
2025
Q2
$317K Sell
6,855
-79
-1% -$3.88K 0.16% 53
2025
Q1
$423K Hold
6,934
0.24% 45
2024
Q4
$392K Buy
+6,934
New +$387K 0.23% 45

Other funds holding BMY

Causey Wealth LLC's BMY Position: Q2 2026 in Review

Causey Wealth LLC held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 7,262 shares worth $418K. The position accounts for 0.16% of the portfolio, ranked #61.

Causey Wealth LLC first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $440K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Causey Wealth LLC held 7,262 shares of Bristol-Myers Squibb worth $418K as of Q2 2026.
  • Causey Wealth LLC left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.16% of Causey Wealth LLC's portfolio in Q2 2026, its #61 holding.
  • Causey Wealth LLC first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Causey Wealth LLC's Bristol-Myers Squibb position peaked at $440K in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Causey Wealth LLC's 13F filing for Q2 2026, filed 11 Aug 2026.